Evaluation of the safety and immunogenicity of synthetic Aß42 (AN1792) in patients with AD.

Autor: Bayer AJ, Bullock R, Jones RW, Wilkinson D, Paterson KR, Jenkins L, Millais SB, Donoghue S
Zdroj: Neurology; 2005 Jan 11, Vol. 64 Issue 1, p94-101, 8p
Databáze: Complementary Index